Clinical Trial Update: Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHF [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating clevidipine versus placebo or standard of care for dyspnea and blood pressure control in acute heart failure was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• clevidipine (clevidipine)

Snippet

Sponsor: The Medicines Company | Conditions: Dyspnea, Hypertension | Phase 3 | Status: WITHDRAWN